Personalized Medicine Market (By Product: Therapeutics, Diagnostics, Personalized Nutrition & Wellness, Personalized Medical Care) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Personalized Medicine
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Personalized Medicine Market By Product
1.2.2.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Personalized Medicine Market Revenue Share By Product in 2017
1.2.2.3. Therapeutics
1.2.2.4. Diagnostics
1.2.2.5. Personalized Nutrition & Wellness
1.2.2.6. Personalized Medical Care
1.2.3. Personalized Medicine Market by Geography
1.2.3.1. Global Personalized Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Personalized Medicine Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Personalized Medicine Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Personalized Medicine Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Personalized Medicine Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Personalized Medicine Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Personalized Medicine Major Manufacturers in 2017
CHAPTER 4. PERSONALIZED MEDICINE MARKET BY PRODUCT
4.1. Global Personalized Medicine Revenue By Product
4.2. Therapeutics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Diagnostics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Personalized Nutrition & Wellness
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Personalized Medical Care
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. NORTH AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY
5.1. North America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Personalized Medicine Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
CHAPTER 6. EUROPE PERSONALIZED MEDICINE MARKET BY COUNTRY
6.1. Europe Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
CHAPTER 7. ASIA-PACIFIC PERSONALIZED MEDICINE MARKET BY COUNTRY
7.1. Asia-Pacific Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
CHAPTER 8. LATIN AMERICA PERSONALIZED MEDICINE MARKET BY COUNTRY
8.1. Latin America Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
CHAPTER 9. MIDDLE EAST PERSONALIZED MEDICINE MARKET BY COUNTRY
9.1. Middle East Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
CHAPTER 10. AFRICA PERSONALIZED MEDICINE MARKET BY COUNTRY
10.1. Africa Personalized Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Personalized Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. Illumina, Inc.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Danaher Corporation
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Asuragen, Inc.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. GE Healthcare
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Dako A/S
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Exagen Diagnostics, Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Exact Science Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Decode Genetics, Inc.
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. QIAGEN
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Celera Diagnostics LLC
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Genelex Corporation
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
11.13. Precision Biologics, Inc.
11.13.1. Company Snapshot
11.13.2. Overview
11.13.3. Financial Overview
11.13.4. Product Portfolio
11.13.5. Key Developments
11.13.6. Strategies
11.14. Biogen, Inc.
11.14.1. Company Snapshot
11.14.2. Overview
11.14.3. Financial Overview
11.14.4. Product Portfolio
11.14.5. Key Developments
11.14.6. Strategies
11.15. Others
11.15.1. Company Snapshot
11.15.2. Overview
11.15.3. Financial Overview
11.15.4. Product Portfolio
11.15.5. Key Developments
11.15.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
Frequently Asked Questions
What are personalized medicines?
Personalized medicines are medicines that are based on individual patients or planned patient groups with certain biomarkers and are designed to meet the patient's needs depending on the patient's reaction to a specific disease.
Which factor curbs the growth of personalized medicine market?
Personalized medical markets are anticipated to grow rapidly, owing to the increased incidence of disease and a deep focus on the development of cancer patients with greater efficacy than other treatments.
What will be the value of personalized medicine market in the forecast period 2019 to 2026?
According to Acumen Research and Consulting, the personalized medicine market value is anticipated to be worth around US$ 1.7 trillion in 2026.
At what CAGR is the personalized medicine market projected to grow during 2019 to 2026?
The personalized medicine market is anticipated to grow over 9.1% CAGR during the forecast period 2019 to 2026.
Which region held the maximum share for the personalized medicine market?
Due to government incentives for hydro-turbine technology, North America is projected to have important demand for Personalized Medicines over the next 6 years.
Which was biggest product segment in 2018?
The biggest product segment in 2018 was personalized nutrition & wellness.
Which region is projected to grow at a fastest rate for the personalized medicine market during the forecast period?
However, Asia Pacific is expected to be the largest CAGR during the forecast period, as freshly developed medical and diagnostic products will cost very little for clinical trials.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
